Canopy Growth Soars 12.03% on Trump's Marijuana Rescheduling Consideration

On August 12, 2025, Canopy Growth's stock surged by 12.03% in pre-market trading, marking a significant rise in the company's share price.

This surge in Canopy Growth's stock price can be attributed to the recent news that President Donald Trump is considering rescheduling marijuana as a less dangerous drug under the Controlled Substances Act. This potential change in federal policy has sparked a rally in Canadian cannabis stocks, with Canopy Growth being one of the key beneficiaries.

The news of Trump's consideration to reschedule marijuana has been met with enthusiasm by investors, who see this as a potential game-changer for the cannabis industry. The move could lead to increased legalization and acceptance of marijuana, opening up new opportunities for companies like Canopy Growth to expand their operations and reach new markets.

As the cannabis industry continues to evolve, Canopy Growth's stock price is likely to remain volatile, with investors closely monitoring any developments in federal policy. However, the recent surge in the company's share price suggests that there is significant optimism about the future of the cannabis industry and Canopy Growth's role within it.